American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

PURPOSE: To update the 2002 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. METHODS: A literature search identified relevant randomized trials published since 2002. Primary outcome of interest was BC incidence (invasive and noninv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Visvanathan, Kala, Chlebowski, Rowan T., Hurley, Patricia, Col, Nananda F., Ropka, Mary, Collyar, Deborah, Morrow, Monica, Runowicz, Carolyn, Pritchard, Kathleen I., Hagerty, Karen, Arun, Banu, Garber, Judy, Vogel, Victor G., Wade, James L., Brown, Powel, Cuzick, Jack, Kramer, Barnett S., Lippman, Scott M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Asco Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716943/
https://ncbi.nlm.nih.gov/pubmed/19470930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.5179
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados